Science2 publishersAlso reported elsewhere2 min readPublished Updated
Northwestern team ties cannabinoid anxiety in mice to one cell group in the fear center
Northwestern scientists traced cannabinoid anxiety in mice to one group of neurons in the amygdala, work reported October 2 in Nature Communications. Silencing those cells left the drugged mice less fearful of a predator odor.
The Scientist · Science desk
Drafted by a language model from the sources cited here and checked against its claim ledger before publication. How we use AISend a correction
What happened
- Before meeting a threatening fox-urine odor, mice were given either a placebo or a synthetic cannabinoid, and the cannabinoid group froze more often and spent less time investigating the scent.
- The researchers watched activity inside the brain through an implanted miniature microscope and ran the test across several different doses of the drug.
- In brain tissue, the drug weakened a natural mechanism that normally restrains the somatostatin neurons, and with that brake eased the cells fired more.
Compiled by The ScientistSomething wrong?How this is made
Why it matters
- capability Switching off one cell type was enough to curb the drug's anxious effect, so a potential target narrows from the brain-wide cannabinoid system to a defined population of neurons.
- constraint The silencing was done with genetic tools in mice, and the team tested whether it lowered anxious behavior, not whether it would preserve the effects people take cannabinoids for.
- precedent Patel casts the same neurons as a possible 'final pathway' for anxiety well beyond cannabis, a larger claim the study did not set out to test.
In the recordings, the somatostatin neurons grew more active as the mice behaved anxiously [4]. That the two rise together does not say one drives the other. The test for cause came from the manipulation: with the neurons genetically silenced, the cannabinoid-treated mice became less likely to avoid the predator odor [5]. It is the first time this cell group has been tied to cannabinoid-driven anxiety [1].
Patel put dose and stress together. "Higher doses of cannabinoids and environmental stress worked together to synergistically release the 'brake' on the central amygdala, which in turn drove excessive anxiety," said Dr. Sachin Patel, the study's senior author and chair of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine [8][9].
"The results of this study could explain why a good trip can turn bad pretty quickly if people consume too much cannabis or the situation they are in turns stressful or scary," Patel said [12].
The work was published October 2 in Nature Communications [2]. Cannabis use in the United States has risen in recent years, and emergency-department visits for the drug's adverse effects have risen with it [10]. Earlier studies link cannabis use to a higher long-term risk of anxiety, an association rather than a demonstrated cause [11]. The release does not report how many mice were tested or how large the effects were.
What to watch
- Whether the effect reproduces with THC or whole cannabis, and whether the full paper reports sample sizes and effect magnitudes.
- Whether suppressing these neurons can ease anxiety without blunting the effects people seek from cannabinoids.
- Whether Patel's 'final pathway' idea holds in anxiety models that have nothing to do with cannabis.